首页> 外文期刊>ancer Biomarkers >MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis
【24h】

MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis

机译:启动子CpG岛高甲基化使MPP3失活在结直肠癌发生中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Drosophila discs large tumor suppressor homologue-3 (MPP3), a putative tumor suppressor involved in cell adhesion and cell polarity, is frequently inactivated in several carcinomas due to promoter hypermethylation. The alteration of MPP3 methylation in colorectal carcinogenesis has not been investigated. nnObjective: To determine the role of inactivated MPP3 in colorectal tumorigenesis and the potential clinical application as a novel epigenetic marker. nnMethods: We measured MPP3 mRNA expression and promoter methylation in 6 colorectal cancer cell lines, 23 primary colorectal carcinomas and corresponding non-cancerous tissues. The correlations between MPP3 expression, DNA methylation and clinicopathological characteristics were evaluated. nnResults: Loss of MPP3 expression was observed in 2 of 6 (33.3%) colorectal cancer cell lines and 10 of 23 (43.5%) primary colorectal carcinomas. MPP3 promoter hypermethylation also occurred in the same colorectal cancer cell lines (SW1116 and LoVo) and 9 of 23 (39.1%) primary colorectal carcinomas. Among tumors loss of MPP3 mRNA expression, the promoter hypermethylation rate was 80%, which was significantly higher than tumors with over-expressed MPP3 (7.7%, P=0.001). After treated with 5-aza-dC, two cell lines (SW1116 and LoVo) revealed significant restoration of MPP3 expression. MPP3 promoter methylation was also significantly higher in advanced colorectal carcinoma (57.1%) compared with early stage tumor (11.1%). nnConclusion: These preliminary data suggested that epigenetic inactivation of MPP3 frequently occurred during the development of colorectal cancer and might also be a potential biomarker for molecular classification of colorectal cancer patients.
机译:背景:果蝇盘大肿瘤抑制物同系物3(MPP3),一种参与细胞粘附和细胞极性的推定肿瘤抑制物,由于启动子过度甲基化而经常在几种癌中失活。尚未研究大肠癌发生过程中MPP3甲基化的改变。目的:确定灭活的MPP3在结直肠肿瘤发生中的作用以及作为新型表观遗传标记物的潜在临床应用。 nn方法:我们测量了6种结直肠癌细胞系,23种原发性结直肠癌及相应的非癌组织中MPP3 mRNA的表达和启动子甲基化。评价MPP3表达,DNA甲基化与临床病理特征之间的相关性。结果:在6个大肠癌细胞系中的2个(33.3%)和23个原发性结肠癌中的10个(43.5%)中观察到了MPP3表达的丧失。 MPP3启动子高甲基化也发生在相同的结直肠癌细胞系(SW1116和LoVo)和23个原发性结直肠癌中的9个(39.1%)中。在MPP3 mRNA表达缺失的肿瘤中,启动子的高甲基化率为80%,显着高于MPP3过表达的肿瘤(7.7%,P = 0.001)。用5-氮杂-dC处理后,两个细胞系(SW1116和LoVo)显示出MPP3表达的显着恢复。与早期肿瘤(11.1%)相比,晚期大肠癌中MPP3启动子甲基化也显着更高(57.1%)。结论:这些初步数据表明,MPP3的表观遗传失活经常在结直肠癌的发展过程中发生,也可能是结直肠癌患者分子分类的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号